Global Peripheral Intravascular Lithotripsy Supply, Demand and Key Producers, 2026-2032
Description
The global Peripheral Intravascular Lithotripsy market size is expected to reach $ 1855 million by 2032, rising at a market growth of 10.8% CAGR during the forecast period (2026-2032).
Peripheral Intravascular Lithotripsy (IVL) is an advanced interventional therapy designed to treat peripheral arterial disease characterized by calcified lesions that cause vascular narrowing or occlusion. This technology employs high-energy acoustic pressure waves at the catheter tip to fracture or modify calcific plaques without damaging surrounding soft tissue, thereby enhancing vessel compliance and facilitating subsequent balloon angioplasty and stent placement. IVL is particularly effective in addressing complex calcifications in peripheral vessels such as the iliac, femoral, and popliteal arteries and serves as a significant complement to traditional angioplasty or atherectomy. With its favorable safety profile and improved vessel revascularization outcomes, IVL is emerging as a critical modality for precision management of calcified lesions in peripheral intervention.The average gross profit margin of this product is 45%.
The growth of peripheral intravascular lithotripsy (IVL) is driven by the rising prevalence of peripheral arterial disease (PAD) and the increasing incidence of vascular calcification. Aging populations, along with the growing burden of chronic conditions such as diabetes and hypertension, have elevated the clinical demand for effective interventions for complex calcified lesions. Advancements in interventional technology have resulted in more precise and minimally invasive plaque modification techniques, offering IVL a favorable safety profile and superior vessel compliance compared with conventional mechanical devices and atherectomy. The growing focus on minimally invasive therapies within hospitals and broader insurance reimbursement frameworks for high-value interventional devices further support IVL adoption and market penetration.
Despite the promising clinical potential of IVL, the industry faces challenges including high device and consumable costs, which elevate overall treatment expenses compared with traditional angioplasty or stenting alone. Variability in reimbursement policies across regions may slow clinical adoption. The complex nature of calcified lesions necessitates advanced operator skill and significant training, posing barriers to widespread implementation. Moreover, regulatory approval pathways for novel interventional technologies require robust safety and long-term efficacy data, which may extend product development and market entry timelines.
Downstream demand demonstrates a shift toward personalized and precision treatment pathways. Patients and clinicians increasingly prioritize safety, durability, and long-term outcomes, particularly for complex calcified lesions and high-risk populations. Large tertiary hospitals and specialized interventional centers represent the primary demand hubs, with secondary facilities gradually adopting IVL as infrastructure and expertise improve. Decentralized care models and chronic disease management frameworks are also catalyzing broader diffusion of peripheral intervention technologies. Integration with real-time imaging guidance systems enhances procedural precision and drives demand for advanced IVL platforms.
Upstream supplies for IVL systems involve advanced high-performance materials, precision manufacturing, and complex electronic control systems. Catheters require high-strength alloys, non-ferromagnetic materials, and elastic polymers with exceptional biocompatibility and fatigue resistance, which are critical for navigability and stability in calcified lesions. Shock wave generation components and acoustic sensors involve micro-machining and high-precision fabrication, with stringent quality standards. Highly integrated control handles, delivery systems, and imaging interfacing hardware depend on mature electronic modules and precision connectors. The upstream supply chain is technology-intensive with high entry barriers, demanding rigorous R&D and quality management capabilities from manufacturers.
This report studies the global Peripheral Intravascular Lithotripsy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Peripheral Intravascular Lithotripsy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peripheral Intravascular Lithotripsy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Peripheral Intravascular Lithotripsy total market, 2021-2032, (USD Million)
Global Peripheral Intravascular Lithotripsy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Peripheral Intravascular Lithotripsy total market, key domestic companies, and share, (USD Million)
Global Peripheral Intravascular Lithotripsy revenue by player, revenue and market share 2021-2026, (USD Million)
Global Peripheral Intravascular Lithotripsy total market by Type, CAGR, 2021-2032, (USD Million)
Global Peripheral Intravascular Lithotripsy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Peripheral Intravascular Lithotripsy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Boston Scientific, Medtronic, Abbott, Cook Medical, Terumo, BD, B. Braun, Cardinal Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Peripheral Intravascular Lithotripsy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Peripheral Intravascular Lithotripsy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Peripheral Intravascular Lithotripsy Market, Segmentation by Type:
IVL Catheters
Energy Generators
Delivery Accessories
Other
Global Peripheral Intravascular Lithotripsy Market, Segmentation by Indication:
Peripheral Artery Disease (PAD)
Dialysis Access (AVF/AVG) Lesions
Coronary
Other
Global Peripheral Intravascular Lithotripsy Market, Segmentation by Treatment Modality:
Standalone IVL
IVL + Balloon
IVL + Stent
Global Peripheral Intravascular Lithotripsy Market, Segmentation by Application:
Hospitals
Ambulatory / OBL Centers
Other
Companies Profiled:
Johnson & Johnson
Boston Scientific
Medtronic
Abbott
Cook Medical
Terumo
BD
B. Braun
Cardinal Health
Key Questions Answered
1. How big is the global Peripheral Intravascular Lithotripsy market?
2. What is the demand of the global Peripheral Intravascular Lithotripsy market?
3. What is the year over year growth of the global Peripheral Intravascular Lithotripsy market?
4. What is the total value of the global Peripheral Intravascular Lithotripsy market?
5. Who are the Major Players in the global Peripheral Intravascular Lithotripsy market?
6. What are the growth factors driving the market demand?
Peripheral Intravascular Lithotripsy (IVL) is an advanced interventional therapy designed to treat peripheral arterial disease characterized by calcified lesions that cause vascular narrowing or occlusion. This technology employs high-energy acoustic pressure waves at the catheter tip to fracture or modify calcific plaques without damaging surrounding soft tissue, thereby enhancing vessel compliance and facilitating subsequent balloon angioplasty and stent placement. IVL is particularly effective in addressing complex calcifications in peripheral vessels such as the iliac, femoral, and popliteal arteries and serves as a significant complement to traditional angioplasty or atherectomy. With its favorable safety profile and improved vessel revascularization outcomes, IVL is emerging as a critical modality for precision management of calcified lesions in peripheral intervention.The average gross profit margin of this product is 45%.
The growth of peripheral intravascular lithotripsy (IVL) is driven by the rising prevalence of peripheral arterial disease (PAD) and the increasing incidence of vascular calcification. Aging populations, along with the growing burden of chronic conditions such as diabetes and hypertension, have elevated the clinical demand for effective interventions for complex calcified lesions. Advancements in interventional technology have resulted in more precise and minimally invasive plaque modification techniques, offering IVL a favorable safety profile and superior vessel compliance compared with conventional mechanical devices and atherectomy. The growing focus on minimally invasive therapies within hospitals and broader insurance reimbursement frameworks for high-value interventional devices further support IVL adoption and market penetration.
Despite the promising clinical potential of IVL, the industry faces challenges including high device and consumable costs, which elevate overall treatment expenses compared with traditional angioplasty or stenting alone. Variability in reimbursement policies across regions may slow clinical adoption. The complex nature of calcified lesions necessitates advanced operator skill and significant training, posing barriers to widespread implementation. Moreover, regulatory approval pathways for novel interventional technologies require robust safety and long-term efficacy data, which may extend product development and market entry timelines.
Downstream demand demonstrates a shift toward personalized and precision treatment pathways. Patients and clinicians increasingly prioritize safety, durability, and long-term outcomes, particularly for complex calcified lesions and high-risk populations. Large tertiary hospitals and specialized interventional centers represent the primary demand hubs, with secondary facilities gradually adopting IVL as infrastructure and expertise improve. Decentralized care models and chronic disease management frameworks are also catalyzing broader diffusion of peripheral intervention technologies. Integration with real-time imaging guidance systems enhances procedural precision and drives demand for advanced IVL platforms.
Upstream supplies for IVL systems involve advanced high-performance materials, precision manufacturing, and complex electronic control systems. Catheters require high-strength alloys, non-ferromagnetic materials, and elastic polymers with exceptional biocompatibility and fatigue resistance, which are critical for navigability and stability in calcified lesions. Shock wave generation components and acoustic sensors involve micro-machining and high-precision fabrication, with stringent quality standards. Highly integrated control handles, delivery systems, and imaging interfacing hardware depend on mature electronic modules and precision connectors. The upstream supply chain is technology-intensive with high entry barriers, demanding rigorous R&D and quality management capabilities from manufacturers.
This report studies the global Peripheral Intravascular Lithotripsy demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Peripheral Intravascular Lithotripsy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Peripheral Intravascular Lithotripsy that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Peripheral Intravascular Lithotripsy total market, 2021-2032, (USD Million)
Global Peripheral Intravascular Lithotripsy total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Peripheral Intravascular Lithotripsy total market, key domestic companies, and share, (USD Million)
Global Peripheral Intravascular Lithotripsy revenue by player, revenue and market share 2021-2026, (USD Million)
Global Peripheral Intravascular Lithotripsy total market by Type, CAGR, 2021-2032, (USD Million)
Global Peripheral Intravascular Lithotripsy total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Peripheral Intravascular Lithotripsy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, Boston Scientific, Medtronic, Abbott, Cook Medical, Terumo, BD, B. Braun, Cardinal Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Peripheral Intravascular Lithotripsy market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Peripheral Intravascular Lithotripsy Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Peripheral Intravascular Lithotripsy Market, Segmentation by Type:
IVL Catheters
Energy Generators
Delivery Accessories
Other
Global Peripheral Intravascular Lithotripsy Market, Segmentation by Indication:
Peripheral Artery Disease (PAD)
Dialysis Access (AVF/AVG) Lesions
Coronary
Other
Global Peripheral Intravascular Lithotripsy Market, Segmentation by Treatment Modality:
Standalone IVL
IVL + Balloon
IVL + Stent
Global Peripheral Intravascular Lithotripsy Market, Segmentation by Application:
Hospitals
Ambulatory / OBL Centers
Other
Companies Profiled:
Johnson & Johnson
Boston Scientific
Medtronic
Abbott
Cook Medical
Terumo
BD
B. Braun
Cardinal Health
Key Questions Answered
1. How big is the global Peripheral Intravascular Lithotripsy market?
2. What is the demand of the global Peripheral Intravascular Lithotripsy market?
3. What is the year over year growth of the global Peripheral Intravascular Lithotripsy market?
4. What is the total value of the global Peripheral Intravascular Lithotripsy market?
5. Who are the Major Players in the global Peripheral Intravascular Lithotripsy market?
6. What are the growth factors driving the market demand?
Table of Contents
94 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Peripheral Intravascular Lithotripsy Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by Indication
- 7 Market Analysis by Treatment Modality
- 8 Market Analysis by Application
- 9 Company Profiles
- 10 Industry Chain Analysis
- 11 Research Findings and Conclusion
- 12 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
